Bindarit

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameBindarit
Drug Alias Name宾达利bindaritumAF-2838
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C motif chemokine 2 inhibitors
TargetsC-C motif chemokine 2
Therapy Area/IndicationsCoronary RestenosisDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySloveniaItaly
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAngelini Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCoronary RestenosisDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksKEGG